MX2008010233A - Modified release composition comprising doxofylline. - Google Patents

Modified release composition comprising doxofylline.

Info

Publication number
MX2008010233A
MX2008010233A MX2008010233A MX2008010233A MX2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A
Authority
MX
Mexico
Prior art keywords
doxofylline
modified release
release composition
pharmaceutically
derivative
Prior art date
Application number
MX2008010233A
Other languages
Spanish (es)
Inventor
Frederick Van Gulik
Madhusudan Rao Yamsani
Ramesh Gannu
Suresh Bandari
Bodapunti Prabha Shakar
Original Assignee
Eurodrug Lab B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodrug Lab B V filed Critical Eurodrug Lab B V
Publication of MX2008010233A publication Critical patent/MX2008010233A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)

Abstract

The invention concerns a modified release doxofylline-based pharmaceutical composition, for administration once a day only, comprising a polymer chosen from a pharmaceutically acceptabel cellulose derivative and a pharmaceutically acceptable methacrylate derivative.
MX2008010233A 2008-03-10 2008-03-10 Modified release composition comprising doxofylline. MX2008010233A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2008/000554 WO2009112874A1 (en) 2008-03-10 2008-03-10 Modified release composition comprising doxofylline

Publications (1)

Publication Number Publication Date
MX2008010233A true MX2008010233A (en) 2009-11-10

Family

ID=40084194

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008010233A MX2008010233A (en) 2008-03-10 2008-03-10 Modified release composition comprising doxofylline.
MX2010009917A MX2010009917A (en) 2008-03-10 2009-03-06 Modified release composition comprising doxofylline.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010009917A MX2010009917A (en) 2008-03-10 2009-03-06 Modified release composition comprising doxofylline.

Country Status (7)

Country Link
EP (1) EP2262485A1 (en)
KR (1) KR101697773B1 (en)
AU (1) AU2009224801B2 (en)
BR (1) BRPI0906158B8 (en)
IT (1) ITMI20080798A1 (en)
MX (2) MX2008010233A (en)
WO (2) WO2009112874A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150063040A (en) * 2012-09-26 2015-06-08 유로드러그 레버러토리즈 비. 브이. Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations
CN103524503B (en) * 2013-10-29 2014-08-06 天津梅花医药有限公司 Doxofylline hemihydrate
CN110898019A (en) * 2019-12-19 2020-03-24 上海宣泰海门药业有限公司 Doxofylline tablet and preparation method thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083372B1 (en) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Sustained release theophyline
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
EP0797987B1 (en) * 1994-12-19 2003-10-15 Daiichi Pharmaceutical Co., Ltd. Sustained-release granular preparation and process for producing the same
US20040087653A1 (en) * 2002-05-16 2004-05-06 Manning Pamela T. Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor
EP2308562B1 (en) * 2003-12-25 2015-02-25 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
AP2007004067A0 (en) * 2005-02-22 2007-08-31 Pfizer Oxyindole derivatives as 5HT4 receptor agonists
WO2007120485A2 (en) * 2006-03-30 2007-10-25 Cinergen, Llc Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
CN100536849C (en) * 2006-05-10 2009-09-09 鲁南制药集团股份有限公司 Medicine composition containing theocin-like medicines and vitamin K
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
CN101028254B (en) * 2007-04-05 2010-05-19 合肥合源医药科技股份有限公司 Sustaining agent of Duosuo theosine and its preparation

Also Published As

Publication number Publication date
AU2009224801A1 (en) 2009-09-17
WO2009112874A1 (en) 2009-09-17
ITMI20080798A1 (en) 2009-09-11
BRPI0906158A2 (en) 2017-07-18
BRPI0906158B1 (en) 2021-01-05
KR101697773B1 (en) 2017-01-18
EP2262485A1 (en) 2010-12-22
KR20100124860A (en) 2010-11-30
MX2010009917A (en) 2010-12-21
BRPI0906158B8 (en) 2021-05-25
WO2009112436A1 (en) 2009-09-17
AU2009224801B2 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
MX2010004323A (en) Oral dosage forms comprising licarbazîžpine acetate.
HK1190909A1 (en) Drug delivery methods, structures, and compositions for nasolacrimal system
JO3757B1 (en) Pharmaceutical compositions comprising nilotinib or its salt
SG169353A1 (en) Tamper resistant dosage forms
IL205360A0 (en) Methods, kits, and compositions for administering pharmaceutical compounds
MX2009003038A (en) 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same.
MX343358B (en) Ulipristal acetate tablets.
BRPI0820997A2 (en) Oral disintegration tablets comprising diphenhydramine.
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
HK1172845A1 (en) Novel pharmaceutical formulations against drug misuse
WO2009071690A3 (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
AP2011005687A0 (en) Sustained release drug delivery system.
TN2011000651A1 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application
TR200904159A1 (en) Modified release emoxipine formulations.
EA200900958A1 (en) DRUG NEVIRAPIN PREPARATION
EP2292242A4 (en) A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof
DE602008002371D1 (en) PHARMACEUTICAL COMPOSITION WITH CANDESARTAN CILEXETIL
WO2011014003A3 (en) (+)-3-hydroxymorphinan derivatives as neuroprotectants
EP2264031A4 (en) A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
MX2008010233A (en) Modified release composition comprising doxofylline.
UA96476C2 (en) Pharmaceutical composition comprising irbesartan
MX349563B (en) Pharmaceutical formulation of nanonised fenofibrate.
TW200833359A (en) Elution-improved pharmaceutical preparation

Legal Events

Date Code Title Description
FG Grant or registration